SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-280725
Filing Date
2022-11-09
Accepted
2022-11-09 07:53:39
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d496724ds3.htm S-3 288366
2 EX-4.4 d496724dex44.htm EX-4.4 287758
3 EX-4.5 d496724dex45.htm EX-4.5 295493
4 EX-5.1 d496724dex51.htm EX-5.1 15548
5 EX-23.1 d496724dex231.htm EX-23.1 1601
6 EX-FILING FEES d496724dexfilingfees.htm EX-FILING FEES 53218
7 GRAPHIC g496724g07p03.jpg GRAPHIC 83501
8 GRAPHIC g496724g1109050852592.jpg GRAPHIC 2953
  Complete submission text file 0001193125-22-280725.txt   1062336
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268260 | Film No.: 221370701
SIC: 2836 Biological Products, (No Diagnostic Substances)